Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02226666 · ClinicalTrials.gov registry record
Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
A clinical trial of Liver Tumor, sponsored by University of Michigan.
- Completed
- Registry status
- 107
- Enrollment target
- 1
- Study location
NCT02226666: Completed study of Liver Tumor, sponsored by University of Michigan.
NCT02226666 is a study of Liver Tumor that has completed, run by University of Michigan. The registered enrollment target is 107 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02226666, a study of Liver Tumor, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to prospectively compare the physiologic response of patients who receive either intravenous gadoxetic acid (Eovist) or intravenous gadobenate dimeglumine (MultiHance).
Primary Outcome
Subjects fill out a short 5-question survey about their MRI experience directly following clinical MRI scan.
Conditions Studied
Interventions
- DRUG MRI with Multihance
- DRUG MRI with Eovist
Study Locations (1)
Michigan
- University of Michigan Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-12 |
What the finished NCT02226666 record still lists
NCT02226666 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Liver Tumor appearing as the primary indexed condition, and to 2 interventions - of which MRI with Multihance is the first listed.
NCT02226666 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02226666 about?
NCT02226666 is a clinical study titled "Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration". The purpose of this study is to prospectively compare the physiologic response of patients who receive either intravenous gadoxetic acid (Eovist) or intravenous gadobenate dimeglumine (MultiHance).
What is the current status of trial NCT02226666?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2013-08. Estimated completion is 2015-12.
What conditions does trial NCT02226666 study?
This clinical trial studies the following conditions: Liver Tumor.
What interventions are being tested in trial NCT02226666?
The interventions under investigation include: MRI with Multihance (DRUG), MRI with Eovist (DRUG).
Who is sponsoring clinical trial NCT02226666?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02226666 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia